Selling And Administration Expenses 更改
Abbott USD 2.69B 10M 2023-12
Aceragen USD 4.92M 32K 2023-03
Alnylam Pharmaceuticals USD 198.12M 1.05M 2023-12
Alterity Therapeutics Limited AUD 2.29M 649.1K 2023-06
Amgen USD 1.76B 424M 2023-12
Biogen USD 608.5M 179.7M 2023-12
BioMarin Pharmaceutical USD 275.02M 51.1M 2023-12
Cipla INR 10.91B 245.2M 2023-09
Clal Biotechnology ILS 3.31M 513K 2022-12
Compugen USD 2.29M 163K 2023-09
CSL USD 1.29B 219.4M 2023-06
Dynavax Technologies USD 39.79M 2.63M 2023-12
Eli Lilly USD 1.92B 120.7M 2023-12
Gilead Sciences USD 1.61B 293M 2023-12
GlaxoSmithKline GBP 2.18B 6M 2023-09
Grifols EUR 300.32M 28.7M 2023-09
Merck USD 2.75B 272M 2023-12
Nektar Therapeutics USD 21.15M 3.28M 2023-09
Pfizer USD 4.47B 1.27B 2023-12
Roche Holding CHF 6.51B 26M 2023-06
Sarepta Therapeutics USD 120.89M 2.33M 2023-09
Ultragenyx Pharmaceutical USD 76.83M 1.92M 2023-12



Aceragen 销售和管理费用 - 当前值,历史数据,预测,统计,图表和经济日历 - Mar 2024.